The Relationship Between Age and Clinical Manifestations and COVID-19 Severity in Bengkulu in 2020

Authors

  • Utari Hartati Suryani Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Dessy Triana Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Riry Ambarsarie Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Zayadi Zainuddin Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Nikki Aldi Massardi Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Begumratu Voca Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu
  • Dia Triyani Putri Faculty of Medicine and Health Sciences, Universitas Bengkulu, Kandang Limun, Bengkulu

DOI:

https://doi.org/10.55324/ijoms.v2i12.643

Keywords:

Infection; Clinical Manifestation; Severity; Pandemic; Covid 19

Abstract

The infectious disease COVID-19 caused by the SARS-CoV-2 virus can infect all age groups. The symptoms that arise can vary from no symptoms to severe and critical symptoms. Differences in clinical symptoms can occur due to differences in the distribution, maturation and function of the SARS-CoV-2 virus receptors. These clinical symptoms will determine the severity of COVID-19. This study aims to analyze the relationship between age and clinical symptoms and the severity of COVID-19 in Bengkulu Province in 2020. This study used an observational analytic study with a cross-sectional design. Samples were taken using a consecutive sampling technique and a total of 109 subjects were obtained who were COVID-19 patients in Bengkulu Province from March to December 2020. Assessment of clinical symptoms used COVID-19 epidemiological investigations. The degree of severity is determined based on the Guidelines for the Prevention and Control of COVID-19 by the Ministry of Health of the Republic of Indonesia. The relationship between the two variables was analyzed using the Spearman Rank test. The results of this study indicate that there is a significant relationship between the age factor of COVID-19 patients in determining the severity of COVID-19 (p=0.000; p <0.05).

References

Aisyah, D. N., Mayadewi, C. A., Diva, H., Kozlakidis, Z., & Adisasmito, W. (2020). A spatial-temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak. PloS One, 15(12), e0243703. https://doi.org/10.1371/journal.pone.0243703.

Ali, I., & Alharbi, O. M. L. (2020). COVID-19: Disease, management, treatment, and social impact. Science of the Total Environment, 728, 138861. https://doi.org/10.1016/j.scitotenv.2020.138861

Bajaj, V., Gadi, N., Spihlman, A. P., Wu, S. C., Choi, C. H., & Moulton, V. R. (2021). Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Frontiers in Physiology, 11, 571416. https://doi.org/10.3389/fphys.2020.571416

Chai, S., Li, Y., Li, X., Tan, J., Abdelrahim, M. E. A., & Xu, X. (2021). Effect of age of COVID?19 inpatient on the severity of the disease: a meta?analysis. International Journal of Clinical Practice, 75(10), e14640. https://doi.org/10.1111/ijcp.14640

Covid, C. D. C., Team, R., Covid, C. D. C., Team, R., Bialek, S., Gierke, R., Hughes, M., McNamara, L. A., Pilishvili, T., & Skoff, T. (2020). Coronavirus disease 2019 in children—United States, february 12–april 2, 2020. Morbidity and Mortality Weekly Report, 69(14), 422. https://doi.org/10.15585/mmwr.mm6914e4

Galbadage, T., Peterson, B. M., & Gunasekera, R. S. (2020). Does COVID-19 spread through droplets alone? Frontiers in Public Health, 8, 163. https://doi.org/10.3389/fpubh.2020.00163

Hofmann, H., Pyrc, K., Van Der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005a). Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences, 102(22), 7988–7993. https://doi.org/10.1073/pnas.0409465102

Hofmann, H., Pyrc, K., Van Der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005b). Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proceedings of the National Academy of Sciences, 102(22), 7988–7993. https://doi.org/10.1073/pnas.0409465102

Li, H., Liu, S.-M., Yu, X.-H., Tang, S.-L., & Tang, C.-K. (2020a). Coronavirus disease 2019 (COVID-19): current status and future perspectives. International Journal of Antimicrobial Agents, 55(5), 105951. https://doi.org/10.1016/j.ijantimicag.2020.105951

Li, H., Liu, S.-M., Yu, X.-H., Tang, S.-L., & Tang, C.-K. (2020b). Coronavirus disease 2019 (COVID-19): current status and future perspectives. International Journal of Antimicrobial Agents, 55(5), 105951. https://doi.org/10.1016/j.ijantimicag.2020.105951

Lingawi, H. S. (2021). Covid-19 in children: prevalence, clinical characteristics, severity, and transmission. J Res Med Dent Sci, 9, 24–30.

Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020). COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta, 508, 254–266. https://doi.org/10.1016/j.cca.2020.05.044

Lu, X., Xiang, Y., Du, H., & Wing?Kin Wong, G. (2020). SARS?CoV?2 infection in children–Understanding the immune responses and controlling the pandemic. Pediatric Allergy and Immunology, 31(5), 449–453.

Manivannan, M., Jogalekar, M. P., Kavitha, M. S., Maran, B. A. V., & Gangadaran, P. (2021). A mini-review on the effects of COVID-19 on younger individuals. Experimental Biology and Medicine, 246(3), 293–297. https://doi.org/10.1177/1535370220975118

Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020). Why does COVID-19 disproportionately affect older people? Aging (Albany NY), 12(10), 9959.

Shoaib, N., Noureen, N., Munir, R., Shah, F. A., Ishtiaq, N., Jamil, N., Batool, R., Khalid, M., Khan, I., & Iqbal, N. (2021). COVID-19 severity: Studying the clinical and demographic risk factors for adverse outcomes. PloS One, 16(8), e0255999. https://doi.org/10.1371/journal.pone.0255999

Song, W., Li, J., Zou, N., Guan, W., Pan, J., & Xu, W. (2020). Clinical features of pediatric patients with coronavirus disease (COVID-19). Journal of Clinical Virology, 127, 104377. https://doi.org/10.1016/j.jcv.2020.104377

Sun, D., Chen, X., Li, H., Lu, X.-X., Xiao, H., Zhang, F.-R., & Liu, Z.-S. (2020a). SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China. World Journal of Pediatrics, 16(3), 260–266. https://doi.org/10.1007/s12519-020-00368-y

Sun, D., Chen, X., Li, H., Lu, X.-X., Xiao, H., Zhang, F.-R., & Liu, Z.-S. (2020b). SARS-CoV-2 infection in infants under 1 year of age in Wuhan City, China. World Journal of Pediatrics, 16, 260–266.

Vahidy, F. S., Pan, A. P., Ahnstedt, H., Munshi, Y., Choi, H. A., Tiruneh, Y., Nasir, K., Kash, B. A., Andrieni, J. D., & McCullough, L. D. (2021). Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PloS One, 16(1), e0245556. https://doi.org/10.1371/journal.pone.0245556

WHO. (2021). WHO Coronavirus Disease (COVID-19).

Yonker, L. M., Neilan, A. M., Bartsch, Y., Patel, A. B., Regan, J., Arya, P., Gootkind, E., Park, G., Hardcastle, M., & John, A. S. (2020). Pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): clinical presentation, infectivity, and immune responses. The Journal of Pediatrics, 227, 45–52.

Zare-Zardini, H., Soltaninejad, H., Ferdosian, F., Hamidieh, A. A., & Memarpoor-Yazdi, M. (2020). Coronavirus disease 2019 (COVID-19) in children: prevalence, diagnosis, clinical symptoms, and treatment. International Journal of General Medicine, 13, 477.

Downloads

Published

2023-09-25

Issue

Vol. 2 No. 12 (2023): Indonesian Journal of Multidisciplinary Science

Section

Articles

License

Copyright (c) 2023 Utari Hartati Suryani, Dessy Triana, Riry Ambarsarie, Zayadi Zainuddin, Nikki Aldi Massardi, Begumratu Voca, Dia Triyani Putri

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.